PRAMIPEXOLE DIHYDROCHLORIDE (pramipexole dihydrochloride) by PharmaIN is 12. Approved for parkinson's disease, parkinson's disease (pd) (). First approved in 2021.
Drug data last refreshed 19h ago
12.1 Mechanism of Action Pramipexole is a non-ergot dopamine agonist with high relative in vitro specificity and full intrinsic activity at the D 2 subfamily of dopamine receptors, binding with higher affinity to D 3 than to D 2 or D 4 receptor subtypes. The precise mechanism of action of…
Worked on PRAMIPEXOLE DIHYDROCHLORIDE at PharmaIN? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions
Pramipexole Dihydrochloride 0.25 mg Tablets Under Fasting Conditions